Sign in
CompletedNo phase

Smartphone Training for Attention Regulation for IBS

Key facts

Who runs it
Carnegie Mellon University
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Completed
People taking part
359 people enrolled
Started
1 Mar 2022
Ended
14 Feb 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mindfulness and Attention Training
  • Mindfulness training
  • Coping Condition
Record updated
26 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Rome IV IBS diagnosis
  • Indicate moderate to high levels of psychological distress over the past two weeks (composite score >=4 on the Patient Health Questionnaire-4)
  • Willingness to provide assessments of bowel symptoms and complete study measures (including smartphone assessments)
  • Willingness/availability to be randomized and participate in all study activities

Who cannot take part

  • Begun any new treatments for IBS in the four weeks prior to baseline
  • Report a new diagnosis of a (non-acute) medical or psychiatric condition requiring treatment within the last 3 months
  • Have a history of diagnosed IBD or gastrointestinal malignancies
  • CGI Interview Only: Is a patient of Dr. David Levinthal; Cold Challenge Sub-study. Exclusion criteria: an existing pain condition, Reynaud's disease, history of heart/cardiovascular disease, high blood pressure, recent injuries, circulatory disorders, current or past frostbite, open cuts, or sores in both hands, a history of seizures, asthma, sickle cell disease or trait, cerebrovascular disease, a recent stroke or heart attack, or anxiolytic medication (e.g., Ativan, Xanax) or pain medication (e.g., aspirin) taken in the 2 hours prior to the study, pregnant or might be pregnant, and/or have a tendency/history of fainting after vaccines, shots, and/or blood draws. Participants will be excluded if they have taken anxiolytic medication (e.g., Ativan, Xanax) or pain medication (e.g., aspirin) taken in the 2 hours prior to the lab session. Participants who report viral illness (e.g., cold) and/or negative physical health symptoms (e.g., stomachache, nausea, fever, dehydration, hunger, sleep deprivation) before the start of the session will also be excluded; As they will be visiting our laboratory on campus, participants will now be required to show proof of COVID-19 vaccination to participate in the study. Participants must also show proof of a booster shot, if they do not have one, they will be asked to wear a mask at in-person sessions to participate. Moving forward, we will continue to follow CMU COVID protocols
  • Non-English speaking
  • Currently pregnant
  • Had a colonoscopy within 2 weeks of enrolling in the study or within the first 4 weeks of study procedures

Where in United States

  • Carnegie Mellon UniversityPittsburgh, United States

About the trial

What the trial wants to find out

In the largest and most well-controlled randomized control trial of mindfulness-based interventions (MBIs) training in irritable bowel syndrome (IBS) to-date (N=360), the investigators will evaluate whether a smartphone MBI program (with attention monitoring and acceptance skills training; Monitor+Accept, MA-MBI) reduces daily life stress and IBS symptoms at post-treatment and two-month follow-up, relative to a matched MBI program with acceptance skills training removed (training in attention monitoring skills only; Monitor Only, MO-MBI) or to an active stress management training control group (Coping Control, CC). Participants will not only provide clinician and patient assessed measures of IBS symptoms at the three time points, but they will also provide sensitive experience sampling assessments (using Ecological Momentary Assessment) of their stress and symptoms in daily life at each time point. Finally, as an exploratory aim, participants will provide stool samples at baseline and post-intervention to provide the first ever test of whether MBIs can alter the gut microbiome in IBS. We will also conduct a sub-study that will include completion of a cold-water challenge performance task to test individuals' distress tolerance.

The 3 groups in the trial

  • Monitor & Accept (MA-MBI)Existing treatment, for comparison

    14-day smartphone based mindfulness meditation attention monitoring and acceptance skills training intervention consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.

    Treatment: Mindfulness and Attention Training

  • Monitor Only (MO-MBI)Existing treatment, for comparison

    14-day smartphone based mindfulness meditation training intervention consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.

    Treatment: Mindfulness training

  • Coping Condition (CC)Existing treatment, for comparison

    14-day smartphone based training intervention focused on coping strategies consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.

    Treatment: Coping Condition

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smartphone Stress Management Training for Irritable Bowel Syndrome
Record updated
26 March 2025